Wild-type p53 can down-modulate the activity of various promoters - PubMed (original) (raw)
Wild-type p53 can down-modulate the activity of various promoters
D Ginsberg et al. Proc Natl Acad Sci U S A. 1991.
Abstract
The wild-type (wt) p53 protein is the product of a tumor suppressor gene that is a frequent target for inactivation in many types of tumors. The nuclear localization of the protein, as well as additional features, suggest that it may be involved in the regulation of gene expression. To explore this possibility, the effects of overproduced wt p53 were investigated in a number of systems. Induction of growth arrest via the antiproliferative effect of wt p53 greatly impaired the ability of cells to exhibit an increase in c-fos mRNA upon serum stimulation. Experiments in which cells were cotransfected with p53 expression plasmids together with a reporter gene linked to various promoters revealed that wt p53 could effectively reduce transcription from a series of promoters derived from serum-inducible genes, but not from a major histocompatibility complex gene. The p53-mediated repression of c-fos gene expression occurred even in the presence of cycloheximide. Kinetic studies indicate that the effect of wt p53 is rapid, rather than representing a secondary consequence of growth arrest. These findings support a role for p53 in transcriptional regulation, perhaps by reducing the expression of genes that are needed for ongoing cell proliferation.
Similar articles
- Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product.
Santhanam U, Ray A, Sehgal PB. Santhanam U, et al. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7605-9. doi: 10.1073/pnas.88.17.7605. Proc Natl Acad Sci U S A. 1991. PMID: 1652755 Free PMC article. - [Gene product p53 is involved in the regulation of activity of the c-fos proto-oncogene promotor].
Vikhanskaia FL, Pospelova TV, Volkov IV, Kukushkin AN, Svetlikova SB, Poslepov VA. Vikhanskaia FL, et al. Dokl Akad Nauk SSSR. 1991;321(4):846-9. Dokl Akad Nauk SSSR. 1991. PMID: 1806357 Russian. No abstract available. - Repression of interleukin-2 and interleukin-4 promoters by tumor suppressor protein p53.
Pesch J, Brehm U, Staib C, Grummt F. Pesch J, et al. J Interferon Cytokine Res. 1996 Aug;16(8):595-600. doi: 10.1089/jir.1996.16.595. J Interferon Cytokine Res. 1996. PMID: 8877730 - Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.
Deb S, Jackson CT, Subler MA, Martin DW. Deb S, et al. J Virol. 1992 Oct;66(10):6164-70. doi: 10.1128/JVI.66.10.6164-6170.1992. J Virol. 1992. PMID: 1356162 Free PMC article. - Tumor-derived p53 mutant C174Y is a gain-of-function mutant which activates the fos promoter and enhances colony formation.
Preuss U, Kreutzfeld R, Scheidtmann KH. Preuss U, et al. Int J Cancer. 2000 Oct 15;88(2):162-71. doi: 10.1002/1097-0215(20001015)88:2<162::aid-ijc3>3.0.co;2-m. Int J Cancer. 2000. PMID: 11004663
Cited by
- Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription.
Lechner MS, Mack DH, Finicle AB, Crook T, Vousden KH, Laimins LA. Lechner MS, et al. EMBO J. 1992 Aug;11(8):3045-52. doi: 10.1002/j.1460-2075.1992.tb05375.x. EMBO J. 1992. PMID: 1379175 Free PMC article. - The first 30 years of p53: growing ever more complex.
Levine AJ, Oren M. Levine AJ, et al. Nat Rev Cancer. 2009 Oct;9(10):749-58. doi: 10.1038/nrc2723. Nat Rev Cancer. 2009. PMID: 19776744 Free PMC article. Review. - Tight DNA binding and oligomerization are dispensable for the ability of p53 to transactivate target genes and suppress transformation.
Shaulian E, Zauberman A, Milner J, Davies EA, Oren M. Shaulian E, et al. EMBO J. 1993 Jul;12(7):2789-97. doi: 10.1002/j.1460-2075.1993.tb05940.x. EMBO J. 1993. PMID: 8334995 Free PMC article. - Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells.
Schwaller J, Koeffler HP, Niklaus G, Loetscher P, Nagel S, Fey MF, Tobler A. Schwaller J, et al. J Clin Invest. 1995 Mar;95(3):973-9. doi: 10.1172/JCI117806. J Clin Invest. 1995. PMID: 7883998 Free PMC article. - The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.
Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L, Debussche L. Venot C, et al. EMBO J. 1998 Aug 17;17(16):4668-79. doi: 10.1093/emboj/17.16.4668. EMBO J. 1998. PMID: 9707426 Free PMC article.
References
- EMBO J. 1983;2(7):1041-7 - PubMed
- Genes Dev. 1991 Feb;5(2):151-9 - PubMed
- Nature. 1984 Mar 8-14;308(5955):199-201 - PubMed
- Nature. 1991 Feb 28;349(6312):802-6 - PubMed
- Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1958-62 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous